This may also account for MDA-MB-435-Hyg breast cancer cells, which, despite clear Myd88, TRAF6 and TRIF expression levels and NF-κB nuclear localization did not show expression of NF-κB target genes. The gene discussed is MYD88; the disease is breast carcinoma.